Pomerantz Law Firm Files a Securities Fraud Lawsuit Against Danske Bank Relating to Money Laundering Scheme

On December 27, 2019, Pomerantz LLP announced that it has filed a securities fraud lawsuit on behalf of several dozen institutional investors in conjunction with the ISAF-Danske Coalition (International Securities Associations and Foundations Management Company for Damaged Danske Investors).

Pomerantz LLP Appointed Lead Counsel in Altria Group, Inc. Securities Litigation

On December 30, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Altria Group and certain of its senior officers concerning the nature of its investment in JUUL Labs, Inc in December, 2018.

Pomerantz LLP Appointed Lead Counsel in International Flavors & Fragrances Inc. Securities Litigation

On December 26, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against International Flavors & Fragrances, Inc, in the United States District Court for the Southern District of New York.

Pomerantz LLP Appointed Lead Counsel in Sarepta Therapeutics Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.

Pomerantz LLP Appointed Lead Counsel in Community Health Systems, Inc. Securities Litigation

On November 20, 2019, Pomerantz LLP was appointed Lead Counsel in Padilla v. Community Health Systems, Inc., a securities class action litigation in the Middle District of Tennessee.

Pomerantz Appointed Lead Counsel in Aclaris Therapeutics Securities Litigation

Pomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.

Jeremy Lieberman Interviewed by Lawdragon

Pomerantz Managing Partner featured on Lawdragon. Read here!

Pomerantz LLP Appointed Lead Counsel in Intelligent Systems Corporation Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Intelligent Systems Corporation.

Pomerantz LLP Appointed Lead Counsel in Fred's, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit aganist Fred’s Inc.

Michael Grunfeld Honored as a Law360 Rising Star

Pomerantz is pleased to announce that Partner Michael Grunfeld, has been recognized as a Law360 Rising Star. This prestigious award is given to a select few top litigators under 40 years old “whose legal accomplishments transcend their age.”

Pomerantz LLP Appointed Lead Counsel in CBL & Associates Properties, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action suit against CBL & Associates Properties.

Pomerantz LLP Appointed Lead Counsel in Yang v. Nobilis Health Corp. Securities Litigation

Pomerantz LLP was appointed lead counsel in a class action lawsuit filed against Nobilis Health Corporation.

Pomerantz Achieves Settlement with Fiat Chrysler Automobiles N.V.

Pomerantz achieved a significant victory for investors in Fiat Chrysler on September 5, when U.S. District Judge Jesse M. Furman granted final approval to a $110 million settlement with the automaker. “Counsel has secured a substantial recovery for the class,” the judge said …

Pomerantz LLP Appointed Lead Counsel in Ascena Retail Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Ascena Retail Group, Inc.

Pomerantz LLP Appointed Lead Counsel in 22nd Century Group Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against 22nd Century Group on behalf of investors.

Pomerantz LLP Appointed Lead Counsel in Nabriva Therapeutics plc Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Nabriva Therapeutics.

Pomerantz LLP Appointed Lead Counsel in Boston Scientific Corporation Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Boston Scientific Corporation.

Pomerantz LLP Appointed Lead Counsel in AT&T Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit on behalf of investors against AT&T Inc.

Pomerantz LLP Appointed Lead Counsel in Credit Suisse Securities Litigation

Pomerantz LLP was appointed Co-Lead Counsel in a class action law suit filed against Credit Suisse Group AG on behalf of investors in VelocityShares Daily Inverse VIX MediumTerm exchange-traded notes.

Pomerantz LLP Appointed Lead Counsel in CenturyLink, Inc. Securities Class Action

On June 10, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action law suit filed against CenturyLink, Inc..